Jacob Asset Management of New York’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-42,825
Closed -$111K 68
2023
Q2
$111K Sell
42,825
-18,512
-30% -$55.4K 0.13% 64
2023
Q1
$226K Hold
61,337
0.26% 56
2022
Q4
$109K Sell
61,337
-6,966
-10% -$18.5K 0.13% 65
2022
Q3
$270K Sell
68,303
-3,439
-5% -$21.1K 0.29% 52
2022
Q2
$397K Buy
71,742
+18,335
+34% +$150K 0.4% 48
2022
Q1
$784K Sell
53,407
-15
-0% -$201 0.48% 44
2021
Q4
$844K Buy
53,422
+3,007
+6% +$72.2K 0.38% 52
2021
Q3
$1.62M Buy
50,415
+30,415
+152% +$1.07M 0.59% 43
2021
Q2
$831K Buy
+20,000
New +$822K 0.27% 68

Other funds holding DMTK

Jacob Asset Management of New York's DMTK Position: Q3 2023 in Review

Jacob Asset Management of New York sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2023, closing a stake of 42,825 shares — an estimated $111K sold.

Jacob Asset Management of New York first reported a position in DMTK in Q2 2021 and held it in 9 quarters. The position peaked at $1.62M in Q3 2021. 78 funds tracked by Wall St. Rank hold DMTK as of Q3 2023.

  • Jacob Asset Management of New York reported no remaining DermTech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Jacob Asset Management of New York sold 42,825 DermTech, Inc. Common Stock shares in Q3 2023, an estimated $111K.
  • Jacob Asset Management of New York first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • Jacob Asset Management of New York's DermTech, Inc. Common Stock position peaked at $1.62M in Q3 2021.
  • 78 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2023.

Based on Jacob Asset Management of New York's 13F filing for Q3 2023, filed 1 Nov 2023.